Smith & Nephew (LON:SN) Share Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

Shares of Smith & Nephew plc (LON:SN) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,055.89 ($14.18) and traded as high as GBX 1,140 ($15.31). Smith & Nephew shares last traded at GBX 1,122.50 ($15.07), with a volume of 1,274,729 shares.

Smith & Nephew Trading Down 2.9%

The stock has a market capitalization of £12.31 billion, a PE ratio of 40.41, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The business’s 50-day moving average is GBX 1,088.48 and its two-hundred day moving average is GBX 1,055.89.

Insider Buying and Selling at Smith & Nephew

In other news, insider Jeremy (Jez) Maiden bought 1,855 shares of the stock in a transaction on Thursday, May 1st. The shares were bought at an average price of GBX 1,070 ($14.37) per share, with a total value of £19,848.50 ($26,649.44). 0.19% of the stock is currently owned by company insiders.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.